Retatrutide — Triple Receptor Agonist

Source: American-manufactured | Purity: ≥99% HPLC verified

Retatrutide is a next-generation triple agonist acting on GIP, GLP-1, and glucagon receptors simultaneously. It represents one of the most advanced metabolic research compounds currently available, with a unique triple-receptor mechanism that distinguishes it from dual agonists.

Research Applications

• Triple receptor (GIP/GLP-1/Glucagon) activation studies
• Advanced metabolic regulation research
• Adipose tissue reduction pathway studies
• Energy expenditure and thermogenesis research
• Cardiovascular and liver health metabolic studies

For research purposes only. Not for human consumption.